Peregrine Asset Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-26,953
Closed -$5.52M 66
2022
Q2
$5.52M Buy
+26,953
New +$5.71M 4.02% 6
2019
Q4
Sell
-14,431
Closed -$3.05M 121
2019
Q3
$3.05M Buy
+14,431
New +$3.02M 1.72% 16
2019
Q2
Sell
-29,895
Closed -$4.92M 116
2019
Q1
$4.92M Buy
+29,895
New +$5.29M 2.84% 9
2018
Q4
Sell
-27,310
Closed -$4.65M 84
2018
Q3
$4.65M Buy
+27,310
New +$4.6M 2.11% 21
2017
Q1
Sell
-58,787
Closed -$6.78M 91
2016
Q4
$6.78M Buy
+58,787
New +$6.54M 4.03% 6

Other funds holding CME

Peregrine Asset Advisers's CME Position: Q3 2022 in Review

Peregrine Asset Advisers sold out of CME Group (CME) in Q3 2022, closing a stake of 26,953 shares — an estimated $5.52M sold.

Peregrine Asset Advisers first reported a position in CME in Q4 2016 and held it in 5 quarters. The position peaked at $6.78M in Q4 2016. 1,145 funds tracked by Wall St. Rank hold CME as of Q3 2022.

  • Peregrine Asset Advisers reported no remaining CME Group position as of Q3 2022 after selling out during the quarter.
  • Peregrine Asset Advisers sold 26,953 CME Group shares in Q3 2022, an estimated $5.52M.
  • Peregrine Asset Advisers first reported a position in CME Group in Q4 2016 and held it in 5 quarters.
  • Peregrine Asset Advisers's CME Group position peaked at $6.78M in Q4 2016.
  • 1,145 funds tracked by Wall St. Rank held CME Group as of Q3 2022.

Based on Peregrine Asset Advisers's 13F filing for Q3 2022, filed 9 Nov 2022.